Other

Perspectives from ProVac and partners on the use of economic evidence for decision making
pdficon32 Andrus, J.K. & Walker, D.G. (2015). Perspectives on expanding the evidence base to inform vaccine introductions: Program costing and cost-effectiveness. Vaccine, 33(Suppl 1), A2-3. doi: 10.1016/j.vaccine.2015.01.001. Download
pdficon32 Teerawattananon, N. (2015). A learning experience from price negotiations for vaccines. Vaccine, 33(Suppl 1), A11-2. doi: 10.1016/j.vaccine.2014.12.050. Download
pdficon32 Sanderson, C. (2015). The ProVac Initiative and evolving decision support. Vaccine, 33(Suppl 1), A8-10. doi: 10.1016/j.vaccine.2014.12.049. Download
pdficon32 Molina Aguilera, I.B. (2015). Perspectives on the development and use of economic evidence for immunization decision-making. Vaccine, 33(Suppl 1), A6-7. doi: 10.1016/j.vaccine.2014.12.048. Download
pdficon32 Sosler, S., Kallenberg, J., & Johnson, HL. (2015). Gavi’s balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes. Vaccine, 33(Suppl 1), A4-5. doi: 10.1016/j.vaccine.2014.12.051. Download
pdficon32 Andrus, J.K & Walker, D.G. (2013). Evidence base for new vaccine introduction in Latin America and the Caribbean. Vaccine, 31(Suppl 3), C2-3. doi: 10.1016/j.vaccine.2013.05.074. Download
pdficon32 de Quadros, C. (2013). Historical perspectives on new vaccine introduction in Latin America and the Caribbean. Vaccine, 31(Suppl 3), C4-5. doi: 10.1016/j.vaccine.2013.05.058. Download
pdficon32 Whitney, C.G. & Parashar, U.D. (2013). What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US. Vaccine, 31(Suppl 3), C6-7. doi: 10.1016/j.vaccine.2013.05.051. Download
pdficon32 Hinman, A. Perspectives on sustainable vaccine introduction. Vaccine, 31(Suppl 3), C8-9. doi: 10.1016/j.vaccine.2013.05.053. Download
pdficon32 Glassman, A (2013). Beyond methods and studies: Building institutions for better public spending on vaccination. Vaccine, 31(Suppl 3), C10-1. doi: 10.1016/j.vaccine.2013.05.050. Download
Other references
pdficon32 Bahia, L., Toscano, C.M., Takemoto, M.L. & Vianna Araujo, D. (2013). Systematic review of pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean. Vaccine, 31(Suppl 3), C33-44, doi:10.1016/j.vaccine.2013.05.030. Download
pdficon32 Takemoto, M.L., Bahia, L., Toscano, C.M. & Vianna Araujo, D. (2013). Systematic review of studies on rotavirus disease cost-of-illness and productivity loss in Latin America and the Caribbean. Vaccine, 31(Suppl 3), C45-57. doi:10.1016/j.vaccine.2013.05.031. Download
pdficon32 Alvis-Guzman, N. et al. (2013). Treatment costs of diarrheal disease and all-cause pneumonia among children under-5 years of age in Colombia. Vaccine, 31(Suppl 3), C58-62. doi:10.1016/j.vaccine.2013.05.035. Download
pdficon32 de la Hoz, F., Castañeda-Orjuela, C., Paternina, A. & Alvis-Guzman, N. (2013). Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. Vaccine, 31(Suppl 3), C80-87. doi:10.1016/j.vaccine.2013.05.064. Download
pdficon32 Toscano, C.M. et al. (2013). Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica. Vaccine, 31(Suppl 3), C88-93. doi: 10.1016/j.vaccine.2013.05.036. Download
pdficon32 Oliveira, L.H. et al. (2013). Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. Vaccine, 31(Suppl 3), C99-108. doi: 10.1016/j.vaccine.2013.05.065. Download
pdficon32 Picón, T. et al. (2013). Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data. Vaccine, 31(Suppl 3), C109-113. doi:10.1016/j.vaccine.2013.01.059. Download
pdficon32 Oliveira, L.H. et al. (2013). Systematic documentation of new vaccine introduction in selected countries of the Latin American Region. Vaccine, 31(Suppl 3), C114-22. doi: 10.1016/j.vaccine.2013.05.032. Download

 

This post is also available in: French Spanish